The US Food & Drug Administration’s newly formed liver drug division is now under the direction of hepatologist with the appointment of Frank Anania as acting director of the Division of Hepatology & Nutrition.
The dedicated liver drug review division was formed as part of the broad reorganization of the Office of New Drugs...